These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 29752131

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue.
    Omeñaca F, Garcia-Sicilia J, García-Corbeira P, Boceta R, Romero A, Lopez G, Dal-Ré R.
    Pediatrics; 2005 Dec; 116(6):1292-8. PubMed ID: 16322149
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine.
    Bayliss J, Nissen M, Prakash D, Richmond P, Oh KB, Nolan T.
    Hum Vaccin Immunother; 2021 Jan 02; 17(1):176-190. PubMed ID: 32573398
    [Abstract] [Full Text] [Related]

  • 27. Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany.
    Kalies H, Verstraeten T, Grote V, Meyer N, Siedler A, Schmitt HJ, Breuer T, Moulton LH, von Kries R, Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland Study Group.
    Pediatr Infect Dis J; 2004 Oct 02; 23(10):944-50. PubMed ID: 15602195
    [Abstract] [Full Text] [Related]

  • 28. Integrated Safety Profile of a New Approved, Fully Liquid DTaP5-HB-IPV-Hib Vaccine.
    Xu J, Stek JE, Ziani E, Liu GF, Lee AW.
    Pediatr Infect Dis J; 2019 Apr 02; 38(4):439-443. PubMed ID: 30882742
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants ≥ 2 and < 43 months of Age: A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study.
    Nakano T, Hasegawa M, Endo M, Matsuda K, Tamai H.
    Vaccine; 2024 Apr 30; 42(12):3134-3143. PubMed ID: 38582691
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F, Knuf M, Heininger U, Jahn K, Collard A, Habermehl P, Schuerman L, Sänger R.
    Vaccine; 2004 Jun 02; 22(17-18):2226-33. PubMed ID: 15149781
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants' vaccination against hepatitis B in general and pediatric practices - the PRALINE study.
    Vié le Sage F, Gaudelus J, Lert F, Dufour V, Texier N, Pouriel M, Schück S, Tehard B, Bréart G.
    Rev Epidemiol Sante Publique; 2016 Jun 02; 64(3):185-94. PubMed ID: 27238163
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.
    Boef AGC, van der Klis FRM, Berbers GAM, Buisman AM, Sanders EAM, Kemmeren JM, van der Ende A, de Melker HE, Rots NY, Knol MJ.
    Vaccine; 2018 Jan 08; 36(3):400-407. PubMed ID: 29223483
    [Abstract] [Full Text] [Related]

  • 38. A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016).
    Guerra A, Costantino C, Martinon-Torres F, Westerholt S, Lambeth C, Chen Z, Lumley J, Marcek T, Johnson D, Wilck M.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2310900. PubMed ID: 38327239
    [Abstract] [Full Text] [Related]

  • 39. Immunogenicity and reactogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus and Haemophilus influenzae type B.
    Shao PL, Lu CY, Hsieh YC, Taiwan Infanrix-049 Study Group, Bock HL, Huang LM.
    J Formos Med Assoc; 2011 May 31; 110(5):336-41. PubMed ID: 21621155
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.